Michelle Bradley

The Identification of Indacaterol as an Ultralong-Acting Inhaled β₂-Adrenoceptor Agonist

François Baur, David T. Beattie, David Beer et al. · Journal of Medicinal Chemistry · 2010 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P₁</scp> receptor internalization

David A. Sykes, Darren Riddy, Craig Stamp et al. · British Journal of Pharmacology · 2014 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

David A. Sykes, Michelle Bradley, Darren Riddy et al. · Molecular Pharmacology · 2016 · 68 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

An investigation into the structure–activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol

David T. Beattie, David Beer, Michelle Bradley et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β2-adrenoceptor agonists as inhaled long-acting bronchodilators

David T. Beattie, Michelle Bradley, Andrew Brearley et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16